关注
Mohammed AL-Jumayli
Mohammed AL-Jumayli
University of South Florida/ Moffitt Cancer Center
在 moffitt.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Factors associated with focal lamina cribrosa defects in glaucoma
SC Park, AT Hsu, D Su, JL Simonson, M Al-Jumayli, Y Liu, JM Liebmann, ...
Investigative ophthalmology & visual science 54 (13), 8401-8407, 2013
1072013
Lamina cribrosa-related parameters assessed by optical coherence tomography for prediction of future glaucoma progression
HS Chung, KR Sung, JY Lee, JH Na
Current eye research 41 (6), 806-813, 2016
342016
Biologics, immunotherapy, and future directions in the treatment of advanced cholangiocarcinoma
A Saeed, R Park, M Al-Jumayli, R Al-Rajabi, W Sun
Clinical Colorectal Cancer 18 (2), 81-90, 2019
332019
Clinical outcome of ampullary carcinoma: single cancer center experience
M Al-Jumayli, A Batool, A Middiniti, A Saeed, W Sun, R Al-Rajabi, ...
Journal of oncology 2019 (1), 3293509, 2019
282019
Immuno-oncotherapeutic approaches in advanced hepatocellular carcinoma
R Park, F Eshrat, M Al-Jumayli, A Saeed, A Saeed
Vaccines 8 (3), 447, 2020
272020
The biological process of aging and the impact of ionizing radiation
M Al-Jumayli, SL Brown, IJ Chetty, M Extermann, B Movsas
Seminars in radiation oncology 32 (2), 172-178, 2022
112022
Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis
OS Akhtar, BA Sheeba, F Azad, L Alessi, D Hansen, M Alsina, R Baz, ...
Journal of Geriatric Oncology, 101628, 2023
72023
Predictors of Toxicity Among Older Adults with Cancer
M Extermann, IJ Chetty, SL Brown, M Al-Jumayli, B Movsas
Seminars in radiation oncology 32 (2), 179-185, 2022
72022
Exceptional response to erlotinib monotherapy in EGFR exon 19-deleted, KRAS wild-type, chemo-refractory advanced pancreatic adenocarcinoma
R Park, M Al-Jumayli, K Miller, A Saeed, A Saeed
Cancer Treatment and Research Communications 27, 100342, 2021
72021
Update on the role of poly (ADP-ribose) polymerase inhibitors in the DNA repair-deficient pancreatic cancers: a narrative review
A Kasi, M Al-Jumayli, R Park, J Baranda, W Sun
Journal of Pancreatic Cancer 6 (1), 107-115, 2020
72020
Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study
A Saeed, H Hildebrand, R Park, M Al-Jumayli, S Abbasi, T Melancon, ...
Journal of Clinical Medicine, 2020
62020
Pre-operative_CarboplatinPaclitaxel_Versus_5-Fluorouracil_5-FU-based_Chemoradiotherapy_for_Older_Adults_With_Esophageal_Cancer?
ASA Mohammed AL-Jumayli, Khalil, Ammar AL-Obaidi
Anticancer research, 2022
52022
Simple score of albumin and CRP predicts high-grade toxicity in patients with multiple myeloma receiving CAR-T therapy
OS Akhtar, K Modi, J Kim, L Skelson, E Smith, MA Al-Jumayli, ...
Transplantation and cellular therapy 30 (3), 283. e1-283. e10, 2024
42024
Evaluation of employment loss and financial hardship among US adults with disabilities during the COVID-19 pandemic
OT Nguyen, J Lee, AA Tabriz, YR Hong, M Al Jumayli, M Reblin, K Turner
JAMA Network Open 6 (3), e233364-e233364, 2023
32023
Potential interaction of radiation therapy, antibiotic, and steroid use in non-small cell lung cancer patients treated with checkpoint inhibitors; A retrospective analysis"
F Wang, ...
ASCO 2019, 2019
32019
CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response
OS Akhtar, B Cao, X Wang, P Torka, M Al-Jumayli, FL Locke, CL Freeman
Blood Advances 7 (19), 5937-5940, 2023
22023
Association of frailty and high-risk immuno-nutritional score with outcomes in patients with relapsed and refractory multiple myeloma treated with chimeric antigen receptor T …
K Modi, OS Akhtar, M Al-Jumayli, M Extermann, M Booth-Jones, ...
Journal of Clinical Oncology 41 (16_suppl), 12052-12052, 2023
22023
221 Poor performance status negatively affects survival benefit of immunotherapy in non-small cell lung cancer
H Kawsar, P Gaudel, N Suleiman, M Al-Jumayli, C Huang, P Neupane
Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020
22020
Abstract B29: Outcomes of DNA repair-deficient pancreatic cancers: KU Cancer Center experience
A Kasi, S Bajwa, M Al-Jumayli, A Saeed, A Godwin
Cancer Research 79 (24_Supplement), B29-B29, 2019
22019
The effect of radiotherapy on clinical outcomes for patients receiving immunotherapy for metastatic non-small cell lung carcinoma
KA D'Rummo, M Al-Jumayli, CH Huang, F Wang
International Journal of Radiation Oncology, Biology, Physics 105 (1), E501-E502, 2019
22019
系统目前无法执行此操作,请稍后再试。
文章 1–20